Mohammad Rahmati-Yamchi

7PUBLICATIONS
13CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Predictive and prognostic markersCellular interactions (incl. adhesion, matrix, cell wall)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
Galangin's Therapeutic Potential in Retinoblastoma: Inducing Apoptosis and Modulating RB Protein and Some MicroRNAs.

|Jul 10, 2025
Targeted Delivery of Bortezomib Using Retinoid-Based Nanoparticle: Modulating Liver Fibrosis through the TGF-β1/Smad3 Pathway.

Samaneh Siapoush, Mohammad Rahmati, Morteza Milani

|Jan 25, 2025
MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes.

Maryam Zamani Sani, Mohammad Mirzaei, Ali Mota

|Jul 16, 2020
The Effect of Beta-Boswellic Acid on the Expression of Camk4 and Camk2α Genes in the PC12 Cell Line.

Asiyeh Jebelli, Mohammad Khalaj-Kondori, Mohammad Rahmati-Yamchi

|Oct 09, 2019
Positive Effects of PI3K/Akt Signaling Inhibition on PTEN and P53 in Prevention of Acute Lymphoblastic Leukemia Tumor Cells.

Elahe Naderali, Behnaz Valipour, Amir Afshin Khaki

|Apr 24, 2019
Purification of a Novel Anti-VEGFR2 Single Chain Antibody Fragment and Evaluation of Binding Affinity by Surface Plasmon Resonance.

Shirafkan Kordi, Mohammad Rahmati-Yamchi, Mehdi Asghari Vostakolaei

Pageof 2

Frequent Collaborators

2 joint publications

Amir Afshin Khaki

2 joint publications

Alireza Alihemmati

2 joint publications

Hojjatollah Nozad Charoudeh

2 joint publications

Maryam Zamani Sani